Human T-cell lymphotropic virus type 1 protein Tax (Tax)

Human T-cell lymphotropic virus type 1 (HTLV-1) protein Tax is a 40 kDa viral accessory protein and a potent oncoprotein essential for the replication and pathogenic potential of HTLV-1 [1, 5]. It primarily functions as a transcriptional transactivator, hijacking host cellular machinery to drive viral gene expression from the 5' long terminal repeat (LTR) and constitutively activating the NF-κB pathway [7, 14]. Tax promotes T-cell transformation by deregulating the cell cycle, inhibiting apoptosis, and interfering with DNA repair mechanisms, which leads to significant genomic instability [4, 16]. It is the primary driver of Adult T-cell leukemia/lymphoma (ATL) and the neuroinflammatory condition HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) [6, 21]. While no direct Tax inhibitors are currently clinically approved, therapeutic strategies often focus on inducing its degradation using agents like arsenic trioxide and interferon-alpha [15]. Recent research has also identified kinases such as KDR (VEGFR2) as potential targets whose inhibition leads to Tax degradation [9]. Tax remains a critical target for both antiviral and anticancer drug development due to its central role in viral persistence and cellular immortalization [3, 10].

Other names

Tax-1p40taxp40HTLV-1 transactivator proteinHTLV-1 oncoprotein Tax

Induction of proteasomal degradation of the Tax protein (Arsenic trioxide/Interferon-alpha); Inhibition of viral replication and Tax-mediated transactivation (Zidovudine); Degradation of Tax via KDR (VEGFR2) kinase inhibition (Axitinib).